Guardian’s John Vidal attacks Gates Foundation for links to Monsanto and Cargill (on site funded by Gates Foundation)

The Bill and Melinda Gates Foundation, which is sponsoring the Guardian’s Global development site is being heavily criticised in Africa and the U.S. for getting into bed not just with notorious GM company Monsanto, but also with agribusiness commodity giant Cargill.

Trouble began when a US financial website published the foundation’s annual investment portfolio, which showed it had bought 500,000 Monsanto shares worth around $23 million. This was a substantial increase in the last six months and while it is just small change for Bill and Melinda, it has been enough to let loose their fiercest critics.

But it got worse. South Africa-based watchdog the African Centre for Biosafety then found that the foundation was teaming up with Cargill in a $10 million project to “develop the soya value chain” in Mozambique and elsewhere. Who knows what this corporate-speak really means, but in all probability it heralds the big time introduction of GM soya in southern Africa.

The foundation has never been upfront about its vision for agriculture in the world’s poorest countries, nor the role of controversial technologies like GM. But perhaps it could start the debate here?

In the meantime, it could tell us how many of its senior agricultural staff used to work for Monsanto or Cargill?

Read the full, original article: Why is the Gates foundation investing in GM giant Monsanto?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-23-2026-01_12_57-PM
After Mel Gibson’s Joe Rogan comments, grifters promoting ivermectin, without evidence, as a hantavirus preventive 
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.